Action 301258 SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Suzhou Fushilai Pharmaceutical Co., Ltd.

Actions

301258

CNE1000058W2

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 07/06/2024 		Varia. 5j. Varia. 1 janv.
26,65 CNY +1,87 % Graphique intraday de Suzhou Fushilai Pharmaceutical Co., Ltd. -10,87 % -17,44 %
22/04 Suzhou Fushilai Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
06/02 Suzhou Fushilai Pharmaceutical Co, Ltd (SZSE:301258) annonce un rachat d'actions pour une valeur de 40 millions CNY. (SZSE:301258) annonce un rachat d'actions pour une valeur de 40 millions CNY. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Suzhou Fushilai Pharmaceutical Co., Ltd. Announces Implementation of Final Profit Distribution Plan (A Shares) for 2023, Payable on 12 June 2024
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Suzhou Fushilai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.
Certain A Shares of Suzhou Fushilai Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.
Suzhou Fushilai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.
Suzhou Fushilai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Fushilai Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 million in funding from Suzhou Fushilai Pharmaceutical Co., Ltd.
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Suzhou Fushilai Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for 2022, Payable on 08 June 2023
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022
Suzhou Fushilai Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Certain A Shares of Suzhou Fushilai Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-MAR-2023.
Fushilai Pharmaceutical to Apply for 375 Million Yuan Credit Lines This Year
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves Management Appointments
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Suzhou Fushilai Pharmaceutical Co., Ltd. Final Announces Cash Dividend on A Shares for 2021, Payable on June 8, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 301258
  4. Actualités Suzhou Fushilai Pharmaceutical Co., Ltd.
  5. Autres langues